Coronary risk in Spain and its treatment with lipid-lowering drugs;El riesgo coronario en España y el tratamiento con fármacos hipolipemiantes

Atencion Primaria

Volumn 32, Issue 7, 2003, Pages 420-422

  Maiques Galán, Antonio ^a   Villar Alvarez F ^b   Llor Vilac, C ^c   Torcal Laguna, J ^d  

^a Centro de Salud de Manises   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^d Medicina de Familia y Comunitaria   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

CARDIOVASCULAR RISK; CONFERENCE PAPER; CORONARY ARTERY DISEASE; HUMAN; SPAIN;

EID: 0345257095     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13053463     Document Type: Conference Paper

References (18)

1. Grupo de Prevención Cardiovascular del Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Guía de prevención cardiovascular. Madrid: Sersa, 1996.
2. Villar Álvarez F, Maiques Galán A, Brotons Cuixart C, Torcal Laguna J, Lorenzo Piqueras J, Vilaseca Canals J, et al. Prevención cardiovascular en atención primaria. Aten Primaria 2001;28(Supl 2):13-27.
3. Wood D, De Backe G, Faegerman O, Graham I, Mancia G, Pyörala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other societies on coronary prevention. Eur Heart J 1998;19:1434-503.
4. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An update coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
5. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use multiple-risk-factor assessment equations. A statement for health care professionals from the American Heart Association and American College of Caridology. J Am Coll Cardiol 1999;34:1348-59.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III). JAMA 2001;285: 2486-97.
7. Grundy SM. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation 1999;100:988-98.
8. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol 2003;56:253-61.
9. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a Multiple Ethnic Groups Investigation. J Am Med Assoc 2001;286:180-7.
10. Marrugat J, Fiol M, Sala J, Tormo MJ, Segura A, Muñiz J, et al. Variabilidad geográfica en España en las tasas de incidencia y mortalidad poblacionales por infarto agudo de miocardio en el estudio IBERICA. Gac Sanit 2000;14(Supl 2):81.
11. Masiá R, Pena A, Marrugat J, Sala J, Vila J, Pavesi, et al. High prevalencie of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. J Epidemiol Community Health 1998;52:707-15.
12. Banegas JR, Villar F, Pérez C, Jiménez R, Gil E, Muñiz J, et al. Estudio epidemiológico de los factores de riesgo cardiovascular en la población española de 35 a 64 años. Rev San Hig Púb 1993;67:419-45.
13. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000;21:365-70.
14. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistic in Europe. The burden of cardiovascular disease mortality in Europe. Eur Heart J 1997;18:1231-48.
15. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P, et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999;353:1547-57.
16. Instituto Nacional de Estadística. Defunciones según la causa de muerte 1998. Tomo I. Resultados básicos. Madrid: Instituto Nacional de Estadística, 2001.
17. Instituto Nacional de Estadística. Encuesta de morbilidad hospitalaria. Años 1989-1999. Madrid: Instituto Nacional de Estadística, 2002.
18. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.